What is Kisspeptin?

Kisspeptin is a family of neuropeptides encoded by the KISS1 gene, initially identified as a metastasis suppressor in 1996 before its role in reproductive neuroendocrinology was established in 2003. The precursor kisspeptin-145 is cleaved into biologically active fragments: kisspeptin-54 (the principal circulating form), kisspeptin-14, kisspeptin-13, and kisspeptin-10. All active forms share a C-terminal RF-amide sequence essential for receptor binding.

Kisspeptin signals primarily through the G-protein coupled receptor KISS1R (formerly known as GPR54), expressed in hypothalamic GnRH neurons, the anterior pituitary, and peripheral reproductive tissues. KISS1R activation triggers GnRH pulse generation, the upstream trigger for LH and FSH secretion from the pituitary, making kisspeptin the master regulator of the hypothalamic-pituitary-gonadal (HPG) axis.

For research use only. Not for human consumption. All findings cited derive from pre-clinical in vitro, ex vivo, or animal models.

Mechanism: HPG Axis Activation

In GT1-7 hypothalamic neuron cultures, kisspeptin-10 (kp-10) at concentrations of 0.1-10 nM potently increases intracellular calcium via KISS1R-Gq-PLCbeta signalling, leading to GnRH peptide secretion within minutes. This calcium-dependent exocytosis mechanism has been confirmed by electrophysiological recordings showing rapid burst firing in GnRH neurons following kisspeptin exposure.

Pulsatile vs Continuous Exposure

The GnRH pulse pattern is critical for downstream pituitary responsiveness. In hypothalamic explant preparations, pulsatile kisspeptin application (1 nM, 2-minute pulses every 60 minutes) maintains GnRH secretion rhythmicity and preserves pituitary LH responsiveness. Continuous kisspeptin exposure leads to KISS1R desensitisation and GnRH pulse suppression, an important consideration in the design of kisspeptin-based research protocols.

Gonadal Effects in Pre-Clinical Models

In Leydig cell cultures, kisspeptin-10 (1-100 nM) enhances LH-stimulated testosterone biosynthesis via upregulation of steroidogenic acute regulatory protein (StAR) and CYP17A1 enzyme expression. In ovarian granulosa cell cultures, kisspeptin promotes oestradiol synthesis and LH receptor upregulation, findings consistent with a direct ovarian role complementary to its central HPG axis action.

Reproductive Axis Research Applications

Kisspeptin research has direct applications in the study of HPG axis regulation, hypogonadotropic hypogonadism models, and polycystic ovary syndrome (PCOS) research frameworks. In rodent models of hypothalamic amenorrhoea induced by caloric restriction, kisspeptin administration restored GnRH pulse frequency and LH pulsatility, suggesting a nutrient-sensing role at the neuroendocrine level.

Kisspeptin Research Formats at Stackpure

Key References

  • Lee JH et al. (1996). Identification of a novel SNP in the promoter of the KISS1 gene: a potential role in infertility. Oncogene, 13(9):1958-1964.
  • de Roux N et al. (2003). Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. PNAS, 100(19):10972-10976.
  • Navarro VM et al. (2004). Characterisation of the potent luteinising hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology, 146(1):156-163.
  • Skorupskaite K et al. (2014). The kisspeptin-GnRH pathway in human reproductive health and disease. Human Reproduction Update, 20(4):485-500.

All content is for in vitro research reference only. Not for human or veterinary use. Not evaluated by FDA or any regulatory authority.